+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Screening Laboratory Services Market by Service type, Sample Type, End User: Global Opportunity Analysis and Industry Forecast, 2020-2027

  • PDF Icon

    Report

  • 220 Pages
  • July 2020
  • Region: Global
  • Allied Market Research
  • ID: 5141686
The global drug screening laboratory services market was valued at $6,720.43 million in 2019, and is projected to reach $7,050.91 million by 2027, registering a CAGR of 9.4% from 2020 to 2027.



Drug screening is a quick and painless technical analysis of biological samples such as blood, hair, and urine to diagnose presence of illegal, prescription drugs, or its metabolites. Drug screening devices have improved, owing to the introduction of new technologies that offer users with precise and accurate results. Drug screening tests are adopted by employers to maintain a free, healthy, and sober workforce that helps maintain high productivity and an appropriate work environment. Rise in alcohol consumption among youth & elderly population, increase in use of narcotics & illicit drugs at workplace, and over use of prescribed drugs are the key factors that fuel growth of the drug screening laboratory services market. Moreover, technological advancements in drug screening products, surge in applications of these services, and increase in competition among providers boost growth of the global market. Furthermore, the rise in government funding & initiatives for drug testing, increase in patient awareness toward drug screening policies, and adverse effects of drugs & alcohol are other factors that contribute toward growth of the market. However, possible manipulation of drug screening tests, and poor demand in under developed countries are expected to hinder growth of the market.

The drug screening laboratory services market is segmented into service type, sample type, end user, and region. On the basis of service, the market is categorized into workplace drug testing and clinical toxicology. By sample type, it is further divided into urine, oral fluid, breath, hair, and others. On the basis of end user, it is divided into retail, oil & gas, transportation, staffing, government, other workplaces, hospital laboratories, clinical laboratories, and other laboratories. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global drug screening laboratory services market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict market growth are provided in the report.
  • Comprehensive quantitative analysis of the industry from 2019 to 2027 are provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of drug screening used across the globe.
  • Key market players and their strategies have been analysed to understand the competitive outlook of the drug screening laboratory services market.

KEY MARKET SEGMENTS

By Service Type
  • Workplace Drug Testing
  • Clinical Toxicology Testing

By Sample Type
  • Urine Sample
  • Oral Fluid Sample
  • Hair Sample
  • Others

By End User
  • Retail
  • Oil and Gas
  • Transportation
  • Staffing
  • Government
  • Other Workplaces
  • Hospital Laboratories
  • Clinical Laboratories
  • Other Laboratories

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

KEY MARKET PLAYERS
  • Abbott Laboratories (Alere Inc.)
  • Acm Global Laboratories, Inc
  • Clinical Reference Laboratory
  • Quest Diagnostics Incorporated.
  • Laboratory Corporation Of America Holdings
  • Psychemedics
  • Millennium Health
  • Mayo Laboratories For Medical Education and Research
  • Omega Laboratories
  • Precision Diagnostics
  • Cordant Health Solutions

Table of Contents

Chapter 1. Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled in the Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
Chapter 2. Executive Summary
2.1. Key Findings of the Study
2.2. CXO Perspective
Chapter 3. Market Overview
3.1. Market Definition and Scope
3.2. Porter’s Five Force Analysis
3.3. Key Findings
3.3.1. Top Investment Pockets
3.4. Regulations
3.5. Market Share Analysis
3.6. Market Dynamics
3.6.1. Drivers
3.6.1.1. Stringent Government Regulations Regarding Drug Abuse
3.6.1.2. Rise in Awareness Against Drug Abuse
3.6.1.3. Surge in Funding for Drug Screening
3.6.2. Restraints
3.6.2.1. Consideration of Drug Screening as a Violation of Rights
3.6.2.2. Negative Impact of Covid-19 Pandemic on the Drug Screening Market
3.6.3. Opportunities
3.6.3.1. Development of Novel Drug Screening Tests
3.6.3.2. Tapping Emerging Markets
3.7. Covid-19 Impact on the Market
Chapter 4. Drug Screening Laboratory Services Market, by Service Type
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Workplace Drug Testing
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Analysis, by Country
4.3. Clinical Toxicology Testing
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Analysis, by Country
Chapter 5. Drug Screening Laboratory Services Market, by Sample Type
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Urine
5.2.1. Market Size and Forecast
5.2.2. Market Analysis, by Country
5.3. Oral Fluid
5.3.1. Market Size and Forecast
5.3.2. Market Analysis, by Country
5.4. Hair
5.4.1. Market Size and Forecast
5.4.2. Market Analysis, by Country
5.5. Others
5.5.1. Market Size and Forecast
5.5.2. Market Analysis, by Country
Chapter 6. Drug Screening Laboratory Services Market, by End-user
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Retail
6.2.1. Market Size and Forecast
6.2.2. Market Analysis, by Country
6.3. Oil & Gas
6.3.1. Market Size and Forecast
6.3.2. Market Analysis, by Country
6.4. Transportation
6.4.1. Market Size and Forecast
6.4.2. Market Analysis, by Country
6.5. Staffing
6.5.1. Market Size and Forecast
6.5.2. Market Analysis, by Country
6.6. Government
6.6.1. Market Size and Forecast
6.6.2. Market Analysis, by Country
6.7. Other Workplaces
6.7.1. Market Size and Forecast
6.7.2. Market Analysis, by Country
6.8. Hospital Laboratories
6.8.1. Market Size and Forecast
6.8.2. Market Analysis, by Country
6.9. Clinical Laboratories
6.9.1. Market Size and Forecast
6.9.2. Market Analysis, by Country
6.10. Other Laboratories
6.10.1. Market Size and Forecast
6.10.2. Market Analysis, by Country
Chapter 7. Drug Screening Laboratory Services Market, by Region
7.1. Overview
7.1.1. Market Size and Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Drug Screening Laboratory Services Market, by Services
7.2.2.1.2. U.S. Drug Screening Laboratory Services Market, by Sample Type
7.2.2.1.3. U.S. Drug Screening Laboratory Services Market, by End-user
7.2.2.2. Canada
7.2.2.2.1. Canada Drug Screening Laboratory Services Market, by Services
7.2.2.2.2. Canada Drug Screening Laboratory Services Market, by Sample Type
7.2.2.2.3. Canada Drug Screening Laboratory Services Market, by End-user
7.2.2.3. Mexico
7.2.2.3.1. Mexico Drug Screening Laboratory Services Market, by Services
7.2.2.3.2. Mexico Drug Screening Laboratory Services Market, by Sample Type
7.2.2.3.3. Mexico Drug Screening Laboratory Services Market, by End-user
7.2.3. North America Market Size and Forecast, by Services
7.2.4. North America Market Size and Forecast, by Sample Type
7.2.5. North America Market Size and Forecast, by End-user
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Country
7.3.2.1. Germany
7.3.2.1.1. Germany Drug Screening Laboratory Services Market, by Services
7.3.2.1.2. Germany Drug Screening Laboratory Services Market, by Sample Type
7.3.2.1.3. Germany Drug Screening Laboratory Services Market, by End-user
7.3.2.2. France
7.3.2.2.1. France Drug Screening Laboratory Services Market, by Services
7.3.2.2.2. France Drug Screening Laboratory Services Market, by Sample Type
7.3.2.2.3. France Drug Screening Laboratory Services Market, by End-user
7.3.2.3. UK
7.3.2.3.1. UK Drug Screening Laboratory Services Market, by Services
7.3.2.3.2. UK Drug Screening Laboratory Services Market, by Sample Type
7.3.2.3.3. UK Drug Screening Laboratory Services Market, by End-user
7.3.2.4. Italy
7.3.2.4.1. Italy Drug Screening Laboratory Services Market, by Services
7.3.2.4.2. Italy Drug Screening Laboratory Services Market, by Sample Type
7.3.2.4.3. Italy Drug Screening Laboratory Services Market, by End-user
7.3.2.5. Spain
7.3.2.5.1. Spain Drug Screening Laboratory Services Market, by Services
7.3.2.5.2. Spain Drug Screening Laboratory Services Market, by Sample Type
7.3.2.5.3. Spain Drug Screening Laboratory Services Market, by End-user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe Drug Screening Laboratory Services Market, by Services
7.3.2.6.2. Rest of Europe Drug Screening Laboratory Services Market, by Sample Type
7.3.2.6.3. Rest of Europe Drug Screening Laboratory Services Market, by End-user
7.3.3. Europe Market Size and Forecast, by Services
7.3.4. Europe Market Size and Forecast, by Sample Type
7.3.5. Europe Market Size and Forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, and Opportunities
7.4.2. Market Size and Forecast, by Country
7.4.2.1. Japan
7.4.2.1.1. Japan Drug Screening Laboratory Services Market, by Services
7.4.2.1.2. Japan Drug Screening Laboratory Services Market, by Sample Type
7.4.2.1.3. Japan Drug Screening Laboratory Services Market, by End-user
7.4.2.2. China
7.4.2.2.1. China Drug Screening Laboratory Services Market, by Services
7.4.2.2.2. China Drug Screening Laboratory Services Market, by Sample Type
7.4.2.2.3. China Drug Screening Laboratory Services Market, by End-user
7.4.2.3. Australia
7.4.2.3.1. Australia Drug Screening Laboratory Services Market, by Services
7.4.2.3.2. Australia Drug Screening Laboratory Services Market, by Sample Type
7.4.2.3.3. Australia Drug Screening Laboratory Services Market, by End-user
7.4.2.4. India
7.4.2.4.1. India Drug Screening Laboratory Services Market, by Services
7.4.2.4.2. India Drug Screening Laboratory Services Market, by Sample Type
7.4.2.4.3. India Drug Screening Laboratory Services Market, by End-user
7.4.2.5. Rest of Asia-Pacific
7.4.2.5.1. Rest of Asia-Pacific Drug Screening Laboratory Services Market, by Services
7.4.2.5.2. Rest of Asia-Pacific Drug Screening Laboratory Services Market, by Sample Type
7.4.2.5.3. Rest of Asia-Pacific Drug Screening Laboratory Services Market, by End-user
7.4.3. Asia-Pacific Market Size and Forecast, by Services
7.4.4. Asia-Pacific Market Size and Forecast, by Sample Type
7.4.5. Asia-Pacific Market Size and Forecast, by End-user
7.5. LAMEA
7.5.1. Key Market Trends, Growth Factors, and Opportunities
7.5.2. Market Size and Forecast, by Country
7.5.2.1. Brazil
7.5.2.1.1. Brazil Drug Screening Laboratory Services Market, by Services
7.5.2.1.2. Brazil Drug Screening Laboratory Services Market, by Sample Type
7.5.2.1.3. Brazil Drug Screening Laboratory Services Market, by End-user
7.5.2.2. South Africa
7.5.2.2.1. South Africa Drug Screening Laboratory Services Market, by Services
7.5.2.2.2. South Africa Drug Screening Laboratory Services Market, by Sample Type
7.5.2.2.3. South Africa Drug Screening Laboratory Services Market, by End-user
7.5.2.3. Saudi Arabia
7.5.2.3.1. Saudi Arabia Drug Screening Laboratory Services Market, by Services
7.5.2.3.2. Saudi Arabia Drug Screening Laboratory Services Market, by Sample Type
7.5.2.3.3. Saudi Arabia Drug Screening Laboratory Services Market, by End-user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA Drug Screening Laboratory Services Market, by Services
7.5.2.4.2. Rest of LAMEA Drug Screening Laboratory Services Market, by Sample Type
7.5.2.4.3. Rest of LAMEA Drug Screening Laboratory Services Market, by End-user
7.5.3. LAMEA Market Size and Forecast, by Services
7.5.4. LAMEA Market Size and Forecast, by Sample Type
7.5.5. LAMEA Market Size and Forecast, by End-user
Chapter 8. Company Profiles
8.1. Abbott Laboratories (Alere)
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Business Performance
8.2. Quest Diagnostics Incorporated
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Business Performance
8.3. Clinical Reference Laboratory, Inc
8.3.1. Company Overview
8.3.2. Company Snapshot
8.4. Laboratory Corporation of America Holdings
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Business Performance
8.5. Sterling Healthcare Opco, LLC/Cordant Health Solutions
8.5.1. Company Overview
8.5.2. Company Snapshot
8.6. Acm Global Laboratories, Inc
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Key Strategic Moves and Developments
8.7. Omega Laboratories Limited
8.7.1. Company Overview
8.7.2. Company Snapshot
8.8. Psychemedics Corporation
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Business Performance
8.8.5. Key Strategic Moves and Developments
8.9. Precision Diagnostics
8.9.1. Company Overview
8.9.2. Company Snapshot
8.10. Millennium Health
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Key Strategic Moves and Developments
8.11. Mayo Foundation for Medical Education and Research
8.11.1. Company Overview
8.11.2. Company Snapshot

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...